A recent research indicates that increased consumption of vitamin D through dietary intake and exposure to the sun was associated with reduced risk of breast cancer.
As reported in the American Journal of Epidemiology, Monday (20/10), vitamin D can suppress the presence of hormone receptors of cancer, the estrogen receptor (ER) and progesterone receptor (PR).
Hormone receptors can be analogous to the inner ear that will listen to the breast cell signal from the hormone. When the signal is commanded to grow, cancer cells will develop in breast cells that contain receptors.
Cancer will be called ER-positive (ER +) if the cause of development is the result of the receptor for the hormone Estrogen. Meanwhile, if the cause of development is the presence of receptors for the hormone progesterone, called PR-positive (PR +).
Research linking the intake of vitamin D in the presence of hormone receptors was carried by Blackmore KM and colleagues from Mount Sinai Hospital in Ontario, Canada.
Research carried out by comparing 758 patients with breast cancer and 1135 control participants who did not develop the disease. The researchers found that participants who were vitamin D intake was high had 26 percent reduced risk of breast cancer ER and PR, and 21 percent decreased risk of ER or PR tumors.
The study also indicates that vitamin D was associated with reduced risk of breast cancer regardless of whether the tumor is ER or PR status.
Vitamin D is found in foods such as fish oils, fortified foods, such as juice, cereal, and milk, and obtained by other means, such as exposure to sunlight.
As reported in the American Journal of Epidemiology, Monday (20/10), vitamin D can suppress the presence of hormone receptors of cancer, the estrogen receptor (ER) and progesterone receptor (PR).
Hormone receptors can be analogous to the inner ear that will listen to the breast cell signal from the hormone. When the signal is commanded to grow, cancer cells will develop in breast cells that contain receptors.
Cancer will be called ER-positive (ER +) if the cause of development is the result of the receptor for the hormone Estrogen. Meanwhile, if the cause of development is the presence of receptors for the hormone progesterone, called PR-positive (PR +).
Research linking the intake of vitamin D in the presence of hormone receptors was carried by Blackmore KM and colleagues from Mount Sinai Hospital in Ontario, Canada.
Research carried out by comparing 758 patients with breast cancer and 1135 control participants who did not develop the disease. The researchers found that participants who were vitamin D intake was high had 26 percent reduced risk of breast cancer ER and PR, and 21 percent decreased risk of ER or PR tumors.
The study also indicates that vitamin D was associated with reduced risk of breast cancer regardless of whether the tumor is ER or PR status.
Vitamin D is found in foods such as fish oils, fortified foods, such as juice, cereal, and milk, and obtained by other means, such as exposure to sunlight.
Anda sedang membaca artikel tentang
Vitamin D Breast Cancer Risk Press
Dengan url
http://tumorsandcancerhazard.blogspot.com/2011/06/vitamin-d-breast-cancer-risk-press.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Vitamin D Breast Cancer Risk Press
namun jangan lupa untuk meletakkan link
Vitamin D Breast Cancer Risk Press
sebagai sumbernya
0 komentar:
Posting Komentar